{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:35Z","timestamp":1761518975938},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T00:00:00Z","timestamp":1287446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s11912-010-0133-0","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T07:54:29Z","timestamp":1287388469000},"page":"5-10","source":"Crossref","is-referenced-by-count":9,"title":["The Need for Axillary Dissection in Patients with Positive Axillary Sentinel Lymph Nodes"],"prefix":"10.1007","volume":"13","author":[{"given":"Randal L.","family":"Croshaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Erb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary M.","family":"Shapiro-Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,19]]},"reference":[{"key":"133_CR1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM198503143121102","volume":"312","author":"B Fisher","year":"1985","unstructured":"Fisher B, Redmond C, Fisher ER, et al.: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985, 312:674\u2013681.","journal-title":"N Engl J Med"},{"key":"133_CR2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Stewart JA, Julian TB, et al.: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomized phase III trial. Lancet Oncol 2007, 8:881\u2013888.","journal-title":"Lancet Oncol"},{"key":"133_CR3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1245\/s10434-009-0800-2","volume":"17","author":"JV Kiluk","year":"2010","unstructured":"Kiluk JV, Ly QP, Santillan AA, et al.: Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 2010, 17:552\u2013557.","journal-title":"Ann Surg Oncol"},{"key":"133_CR4","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.ejca.2008.11.041","volume":"45","author":"U Veronesi","year":"2009","unstructured":"Veronesi U, Galimberti V, Paganelli G, et al.: Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 2009, 45:1381\u20131388.","journal-title":"Eur J Cancer"},{"key":"133_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","volume":"102","author":"T Ashikaga","year":"2010","unstructured":"Ashikaga T, Krag DN, Land SR, et al.: Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010, 102:111\u2013118.","journal-title":"J Surg Oncol"},{"key":"133_CR6","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Giuliano AE, McCall LM, Beitsch PD, et al.: ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node. J Clin Oncol 2010, 28(Suppl):abstr CRA506. This study reports on a large phase 3 trial to date revealing no benefit of axillary node dissection for patients with clinically node negative but pathologically positive sentinel nodes.","DOI":"10.1200\/jco.2010.28.18_suppl.cra506"},{"key":"133_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000167759.15670.14","volume":"242","author":"Martelli","year":"2005","unstructured":"Martelli: A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: Results after 5 years of follow-up. Ann Surg 2005, 242:1\u20139.","journal-title":"Ann Surg"},{"key":"133_CR8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.amjsurg.2010.01.009","volume":"199","author":"AR Taras","year":"2010","unstructured":"Taras AR, Hendrickson NA, Lowe KA, et al.: Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes. Am J Surg 2010, 199:625\u2013628.","journal-title":"Am J Surg"},{"key":"133_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12282-009-0154-4","volume":"17","author":"H Takei","year":"2010","unstructured":"Takei H, Kurosumi M, Yoshida T, et al.: Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Breast Cancer 2010, 17:9\u201316.","journal-title":"Breast Cancer"},{"key":"133_CR10","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","volume":"27","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Hansen NM, et al.: Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009, 27:2946\u20132953.","journal-title":"J Clin Oncol"},{"key":"133_CR11","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/1097-0142(197810)42:4<2032::AID-CNCR2820420453>3.0.CO;2-O","volume":"42","author":"ER Fisher","year":"1978","unstructured":"Fisher ER, Palekar A, Rockette H, et al.: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) V. Significance of axillary nodal micro-and macrometastases. Cancer 1978, 42:2032\u20132038.","journal-title":"Cancer"},{"key":"133_CR12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejso.2005.01.001","volume":"31","author":"GP Kuijt","year":"2005","unstructured":"Kuijt GP, Voogd AC, van de Poll-Franse LV, et al.: The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 2005, 31:500\u2013505","journal-title":"Eur J Surg Oncol"},{"key":"133_CR13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jamcollsurg.2008.10.036","volume":"208","author":"J Reed","year":"2009","unstructured":"\u2022 Reed J, Rosman M, Verbanac KM, et al.: Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University\/Anne Arundel Medical Center Sentinel Node Multicenter Study. J Am Coll Surg 2009, 208:333\u2013340. The rate of distant recurrence is reported at 4.9 years and reveals increased recurrence risk in patients with isolated tumor cells, micrometastases, and macrometastases in sentinel nodes.","journal-title":"J Am Coll Surg"},{"key":"133_CR14","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1245\/s10434-010-0954-y","volume":"17","author":"PT Truong","year":"2010","unstructured":"\u2022 Truong PT, Lesperance M, Li KH, et al.: Micrometastatic node-positive breast cancer: Long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol 2010, 17:2138\u20132146. This study reports on a large number of patients with N0, N1mi, or N1 disease for 10 years, and reveals statistically significant prognostic information.","journal-title":"Ann Surg Oncol"},{"key":"133_CR15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.22112","volume":"107","author":"DC Maibenco","year":"2006","unstructured":"Maibenco DC, Dombi GW, Kau TY, et al.: Significance of micrometastases on the survival of women with T1 breast cancer. Cancer 2006, 107:1234\u20131239","journal-title":"Cancer"},{"key":"133_CR16","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1245\/s10434-007-9513-6","volume":"14","author":"SL Chen","year":"2007","unstructured":"Chen SL, Hoehne FM, Giuliano AE: The prognostic significant of micrometastases in breast cancer: A SEER population-based analysis. Ann Surg Oncol 2007, 14:3378\u20133384.","journal-title":"Ann Surg Oncol"},{"key":"133_CR17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/jnci\/djq008","volume":"102","author":"M Boer De","year":"2010","unstructured":"De Boer M, Van Dijck JA, Bult P, et al.: Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. J Natl Cancer Inst 2010, 102:410\u2013425.","journal-title":"J Natl Cancer Inst"},{"key":"133_CR18","unstructured":"NCCN Clinical Practice Guidelines in Clinical Oncology, Breast Cancer. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/breast.pdf . Accessed July 29, 2010."},{"key":"133_CR19","unstructured":"American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer, September 12, 2005. Available at: http:\/\/www.asco.org\/ASCOv2\/Practice+%26+Guidelines\/Guidelines\/Clinical+Practice+Guidelines\/Breast+Cancer Accessed July 29, 2010."},{"key":"133_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1245\/s10434-008-0195-5","volume":"16","author":"J Rescigno","year":"2009","unstructured":"Rescigno J, Zampell J, Axelrod D: Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy. Ann Surg Oncol 2009, 16:687\u2013696.","journal-title":"Ann Surg Oncol"},{"key":"133_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archsurg.2009.269","volume":"145","author":"N Wasif","year":"2010","unstructured":"Wasif N, Maggard MA, Ko CY, Giuliano AE: Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer. Arch Surg 2010, 145:161\u2013166.","journal-title":"Arch Surg"},{"key":"133_CR22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1245\/s10434-009-0549-7","volume":"16","author":"N Wasif","year":"2009","unstructured":"Wasif N, Ye X, Giuliano AE: Survey of ASCO members on management of sentinel node micrometastases in breast cancer: Variation in treatment recommendations according to specialty. Ann Surg Oncol 2009, 16:2442\u20132449.","journal-title":"Ann Surg Oncol"},{"key":"133_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jamcollsurg.2007.08.024","volume":"206","author":"CE Cox","year":"2008","unstructured":"\u2022 Cox CE, Kiluk JV, Riker AI, et al.: Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 2008, 206:261\u2013268. This study reports a difference in DFS and OS for patients with micrometastatic disease. However, it failed to show a benefit for axillary dissection in micrometastatic disease.","journal-title":"J Am Coll Surg"},{"key":"133_CR24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa0904832","volume":"361","author":"M Boer De","year":"2009","unstructured":"\u2022\u2022 De Boer M, Van Deurzen CHM, Van Dijck JAAM, et al.: Micrometastasis or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009, 361:653\u2013663. The DFS of patients with micrometastasis and isolated tumor cells based on adjuvant chemotherapy and the possible value of axillary dissection was discussed.","journal-title":"N Engl J Med"},{"key":"133_CR25","doi-asserted-by":"crossref","unstructured":"Meretoja TJ, Vironen JH, Heikkila PS, Leidenius MH: Outcome of selected breast cancer patients with micrometastasis or isolated tumor cells in sentinel node biopsy and no completion axillary lymph node dissection. J Surg Oncol 2010, In press.","DOI":"10.1002\/jso.21608"},{"key":"133_CR26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archsurg.2010.84","volume":"145","author":"S Yegiyants","year":"2010","unstructured":"Yegiyants S, Romero LM, Haigh PI, DiFronzo LA: Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node. Arch Surg 2010, 145:564\u2013569.","journal-title":"Arch Surg"},{"key":"133_CR27","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1245\/s10434-009-0660-9","volume":"16","author":"I Langer","year":"2009","unstructured":"Langer I, Guller U, Viehl CT, et al.: Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 2009, 16:3366\u20133374.","journal-title":"Ann Surg Oncol"},{"key":"133_CR28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1245\/s10434-009-0804-y","volume":"17","author":"S Pernas","year":"2010","unstructured":"Pernas S, Gil M, Benitez A, et al.: Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann Surg Oncol 2010, 17:772\u2013777.","journal-title":"Ann Surg Oncol"},{"key":"133_CR29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1245\/ASO.2006.03.010","volume":"13","author":"N Klauber-DeMore","year":"2006","unstructured":"Klauber-DeMore N, Ollila DW, Moore DT, et al.: Size of residual lymph node metastasis after preoperative chemotherapy in locally advanced breast cancer patients is prognostic. Ann Surg Oncol 2006,13:685\u2013691.","journal-title":"Ann Surg Oncol"},{"key":"133_CR30","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1245\/s10434-009-0612-4","volume":"16","author":"M Sakakibara","year":"2009","unstructured":"\u2022 Sakakibara M, Nagashima T, Kadowaki M, et al.: Clinical significance of axillary microresiduals after neoadjuvant chemotherapy in breast cancer patients with cytologically proven metastasis. Ann Surg Oncol 2009, 16:2470\u20132478. This article reported a statistical difference for DFS and OS in N1 patients who received neoadjuvant chemotherapy.","journal-title":"Ann Surg Oncol"},{"key":"133_CR31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9610(98)00253-0","volume":"176","author":"HM Kuerer","year":"1998","unstructured":"Kuerer HM, Newman LA, Buzdar AU, et al.: Residual metastatic axillary lymph nodes following preoperative chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 1998, 176:502\u2013509.","journal-title":"Am J Surg"},{"key":"133_CR32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00000658-199907000-00011","volume":"230","author":"HM Kuerer","year":"1999","unstructured":"Kuerer HM, Sahin AA, Hunt KK, et al.: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with preoperative chemotherapy. Ann Surg 1999, 230:72\u201378.","journal-title":"Ann Surg"},{"key":"133_CR33","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1200\/JCO.2003.12.005","volume":"21","author":"HD Bear","year":"2003","unstructured":"Bear HD, Anderson S, Brown A, et al.: The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2003, 21:4165\u20134174.","journal-title":"J Clin Oncol"},{"key":"133_CR34","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/j.ejca.2009.04.029","volume":"45","author":"ME Straver","year":"2009","unstructured":"Straver ME, Rutgers EJ, Russell NS, et al.: Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. Eur J Cancer 2009, 45:2284\u20132292.","journal-title":"Eur J Cancer"},{"key":"133_CR35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","volume":"27","author":"JM Classe","year":"2009","unstructured":"\u2022 Classe JM, Bordes V, Campion L, et al.: Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 2009, 27:726\u2013732. This is a small prospective study evaluating the success of SNB after neoadjuvant chemotherapy in patients with N0 and N1 disease.","journal-title":"J Clin Oncol"},{"key":"133_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejso.2009.10.015","volume":"36","author":"V Ozmen","year":"2010","unstructured":"\u2022 Ozmen V, Unal ES, Muslumanoglu ME, et al.: Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol 2010, 36:23\u201329. This study provides evidence on the usefulness of SNB and intraoperative cytopathology to confirmed nodal disease and its prognostic value in patients following neoadjuvant chemotherapy.","journal-title":"Eur J Surg Oncol"},{"key":"133_CR37","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/cncr.24887","volume":"116","author":"GF Schwartz","year":"2010","unstructured":"\u2022 Schwartz GF, Tannebaum JE, Jernigan AM, Palazzo JP: Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Cancer 2010, 116:1243\u20131251. This is a small retrospective study evaluating the authors\u2019 experience with SNB after neoadjuvant chemotherapy.","journal-title":"Cancer"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-010-0133-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-010-0133-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-010-0133-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T15:35:05Z","timestamp":1559748905000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-010-0133-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,19]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1007\/s11912-010-0133-0","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,19]]}}}